Clinical Trials
7 trialsNCT00066586 2020-04-02
Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer
Canadian Cancer Trials Group
Phase NA Completed
NCT01720602 2020-01-07
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy
University of Washington
Phase NA Completed
NCT01153672 2019-09-06
Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy
University of Washington
Phase NA Completed
NCT01385280 2018-10-17
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
University of Arizona
Phase NA Completed
NCT01331421 2018-01-23
Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
West-Ward Pharmaceutical
Phase NA Completed
NCT01331434 2018-01-23
Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions
West-Ward Pharmaceutical
Phase NA Completed
NCT01331447 2018-01-23
Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions
West-Ward Pharmaceutical
Phase NA Completed